Navigation Links
Lexicon to Present at Morgan Stanley Global Healthcare Conference
Date:9/7/2010

THE WOODLANDS, Texas, Sept. 7 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering breakthrough treatments for human disease, announced today that it will be participating next week in the Morgan Stanley Global Healthcare Conference in New York.  Dr. Arthur T. Sands, president and chief executive officer, will make a presentation on the company on Monday, September 13, 2010 at 10:20 a.m. Eastern Time.

A live audio webcast of the presentation will be accessible through Lexicon's corporate website at www.lexpharma.com. An archived edition of the presentation will be available later that day.

About Lexicon

Lexicon is a biopharmaceutical company focused on discovering breakthrough treatments for human disease.  Lexicon currently has four drug candidates in mid-stage development for diabetes, irritable bowel syndrome, carcinoid syndrome and rheumatoid arthritis, all of which were discovered by Lexicon's research team.  Lexicon has used its proprietary gene knockout technology to identify more than 100 promising drug targets.  Lexicon has focused drug discovery efforts on these biologically-validated targets to create its extensive pipeline of clinical and preclinical programs.  For additional information about Lexicon and its programs, please visit www.lexpharma.com.

Safe Harbor Statement

This press release contains "forward-looking" statements, including statements relating to Lexicon's growth and future operating results, discovery and development of products, strategic alliances and intellectual property, as well as other matters that are not historical facts or information
'/>"/>

SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Lexicon to Present at Two Major Healthcare Investor Conferences
2. Lexicon Announces Pricing of Common Stock in Public Offering
3. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Fourth Quarter and Full Year Financial Results
4. Lexicon Announces Proposed Offering of 27,500,000 Shares of Common Stock
5. Lexicon Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
6. Lexicon to Provide Clinical Pipeline Update and Report Second Quarter 2009 Financial Results on July 28, 2009
7. Lexicon Initiates Phase 2 Clinical Trial of LX1032 in Patients With Carcinoid Syndrome
8. Lexicon Names Ajay Bansal Executive Vice President and Chief Financial Officer
9. Lexicon to Present Clinical Data for LX1031 and LX1032 at Digestive Disease Week
10. Lexicon to Provide Clinical Pipeline Update and Report First Quarter 2009 Financial Results on April 28, 2009
11. Lexicon Pharmaceuticals 2008 Annual Report to Stockholders Available Online
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... 27, 2015 Research and Markets ( http://www.researchandmarkets.com/research/p2ddnr/global_market ... Report of Trypsin" report to their offering. , ... at providing comprehensive data on Trypsin globally and regionally ( ... North America , Latin America ... to Trypsin This report focuses on three primary ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 FamilyFarms Group ... General Manager of State Line Farms, received the 2015 ... a producer, under the age of 35, who has ... is an honor to win the Tomorrow's Top Producer ... who won the Top Producer Award and learning from ...
(Date:2/26/2015)... 26, 2015 On behalf of biotech client ... Wilentz, Goldman & Spitzer, P.A. (Wilentz) secured a ... Genewiz Inc. in excess of $10 million. The jury ... secrets, and that it improperly hired one or more ... motions for judgment notwithstanding the verdict, a new trial, ...
(Date:2/26/2015)... 26, 2015 Protiviti ( www.protiviti.com ), a ... the Governance Portal , designed to increase the ... (GRC) tasks across multiple business units and projects. The ... customers better align their controls with the COSO ( ... requirements. In response to client feedback, Protiviti has also ...
Breaking Biology Technology:Global Market Report of Trypsin 2014-2018 2Matt Sims Receives the 2015 Tomorrow’s Top Producer Horizon Award 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 2Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 3
... of the world,s leading environmental scholars are sounding the alarm ... environmental institutions into a more coherent and robust planetary stewardship ... changes to the Earth,s subsystems. University of ... of a paper which appears in Science on ...
... -- Advisor to President Barack Obama for the Office ... visited the Navy,s corporate laboratory, March 16, to dedicate ... (LASR) and tour the sprawling 130-acre Washington, D.C., campus. ... Navy, Marine Corps and our Nation in ever evolving ...
... 15, 2012  Foundation for Health Improvement and Technology ... of its nonprofit, with the mission to rid ... diseases through educational programs promoting early detection and ... biomarker research have made it entirely possible to ...
Cached Biology Technology:Scholars call for global governance overhaul to ensure Earth's sustainability 2White House S&T advisor the Honorable Dr. John Holdren tours Naval Research Laboratory 2Foundation for Health Improvement and Technology (FHIT) Launched to Beat Cardiovascular Disease 2
(Date:2/5/2015)... New Market Research Reports Title ... To 2020 has Been Added to GrandViewReseach.com Report Database ... to reach USD 5.10 billion by 2020, according to ... cameras help identify the site of tissue damage in ... demand in medical imaging applications. They have been extensively ...
(Date:1/22/2015)... 22, 2015 Research and Markets ( http://www.researchandmarkets.com/research/4trb7t/biometrics_a ) ... Global Market Overview" report to their offering. , ... ensure that an individual is who she/he is claiming to ... of a person,s unique physical characteristics, such as fingerprint, hand ...
(Date:1/22/2015)... , Jan. 15, 2015  BellBrook Labs, a leader ... announced the launch of a TR-FRET (time resolved ... Transcreener UDP Assay, a high throughput screening assay ... assay will allow for sensitive detection of hundreds ...
Breaking Biology News(10 mins):IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 3Biometrics - A Global Market Overview 2Biometrics - A Global Market Overview 3BellBrook Labs Launches a High Throughput Screening Assay for Glycosyltransferases with TR-FRET Readout 2
... the full integration of its open access journals ... vision for the long-term availability of open access scholarly ... guarantees Pensoft,s journals will remain intact, securely stored, and ... is participating in the international Global LOCKSS Network supporting ...
... research and higher education institutions is developing a network ... will help doctors to diagnose different types of possible ... time. The seven partners across four European countries, ... the project, known as BIOPOOL, with a budget of ...
... 19, 2013) New findings by Columbia researchers ... (WMHs) may be a second necessary factor for the ... to Alzheimer,s disease focus on the accumulation of amyloid ... Institute for Research on Alzheimer,s Disease and the Aging ...
Cached Biology News:Research secured for the future: Pensoft Publishers takes on CLOCKSS archival technology 2Data pooling in biobanks: The BIOPOOL project 2
Mouse monoclonal [6E10] to LAP2 ( Abpromise for all tested applications). entrezGeneID: 7112 SwissProtID: P42166...
Ephrin A4...
Rad51B...
... - Proliferation Marker, prediluted Ki67 antigen ... protein, expressed by proliferating cells in all ... S, G2 and M phase). It is ... are useful in establishing the cell growing ...
Biology Products: